SeaCrest Wealth Management »

Summit Therapeutics shares owned by SeaCrest Wealth Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by SeaCrest Wealth Management from 13F filings

Historical chart of SeaCrest Wealth Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by SeaCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by SeaCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $483k 23k 21.28
2025-03-31 $481k 25k 19.29
2024-12-31 $444k 25k 17.85